ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $487,760 | -2.4% | 23,405 | +12.2% | 0.00% | 0.0% |
| Q2 2023 | $499,525 | +54.6% | 20,857 | +21.5% | 0.00% | 0.0% |
| Q1 2023 | $323,196 | +13.2% | 17,173 | -4.2% | 0.00% | 0.0% |
| Q4 2022 | $285,430 | +15.6% | 17,929 | +18.8% | 0.00% | +100.0% |
| Q3 2022 | $247,000 | +16.0% | 15,096 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $213,000 | -50.9% | 15,096 | -15.8% | 0.00% | -50.0% |
| Q1 2022 | $434,000 | +12.1% | 17,927 | +8.0% | 0.00% | 0.0% |
| Q4 2021 | $387,000 | +78.3% | 16,593 | +26.7% | 0.00% | +100.0% |
| Q3 2021 | $217,000 | -32.0% | 13,094 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $319,000 | -5.6% | 13,094 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $338,000 | -56.9% | 13,094 | -10.9% | 0.00% | -60.0% |
| Q4 2020 | $785,000 | +44.3% | 14,693 | +11.4% | 0.01% | +25.0% |
| Q3 2020 | $544,000 | -14.9% | 13,187 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $639,000 | +47.6% | 13,187 | +28.8% | 0.01% | +50.0% |
| Q1 2020 | $433,000 | +30.4% | 10,240 | +31.9% | 0.00% | +33.3% |
| Q4 2019 | $332,000 | +44.3% | 7,762 | +21.3% | 0.00% | +50.0% |
| Q3 2019 | $230,000 | +34.5% | 6,397 | 0.0% | 0.00% | +100.0% |
| Q2 2019 | $171,000 | -0.6% | 6,397 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $172,000 | +34.4% | 6,397 | -19.4% | 0.00% | +100.0% |
| Q4 2018 | $128,000 | +8.5% | 7,935 | +39.4% | 0.00% | 0.0% |
| Q3 2018 | $118,000 | +35.6% | 5,693 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $87,000 | -32.0% | 5,693 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $128,000 | -42.6% | 5,693 | -23.1% | 0.00% | -50.0% |
| Q4 2017 | $223,000 | +4.2% | 7,403 | +30.6% | 0.00% | 0.0% |
| Q3 2017 | $214,000 | +94.5% | 5,670 | +43.2% | 0.00% | +100.0% |
| Q2 2017 | $110,000 | -59.3% | 3,960 | -49.5% | 0.00% | -66.7% |
| Q1 2017 | $270,000 | -20.1% | 7,847 | -33.1% | 0.00% | 0.0% |
| Q4 2016 | $338,000 | -9.4% | 11,737 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $373,000 | +262.1% | 11,737 | +269.8% | 0.00% | +300.0% |
| Q2 2016 | $103,000 | +15.7% | 3,174 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $89,000 | +29.0% | 3,174 | +63.9% | 0.00% | 0.0% |
| Q4 2015 | $69,000 | +81.6% | 1,937 | +70.5% | 0.00% | 0.0% |
| Q3 2015 | $38,000 | +192.3% | 1,136 | +274.9% | 0.00% | – |
| Q2 2015 | $13,000 | +30.0% | 303 | 0.0% | 0.00% | – |
| Q1 2015 | $10,000 | -98.7% | 303 | -99.1% | 0.00% | -100.0% |
| Q2 2014 | $791,000 | -7.2% | 35,000 | 0.0% | 0.02% | -11.5% |
| Q1 2014 | $852,000 | – | 35,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |